Home
  • About Us
  • Our Science
  • News
  • Contact & Jobs

« Return to News

Merck Serono and MSM Protein Technologies Establish Drug Discovery Collaboration Targeted to Complex Cell Surface Receptors

07/30/2009

http://www.businesswire.com/news/home/20090730005474/en/%20Merck-Serono-MSM-Protein-Technologies-Establish-Drug



PDF Downloads:

  • 11/20/2013 - MSM Protein Technologies Secures Second Pre-Clinical Debiopharm Milestone
  • 4/10/2013 - MSM satisfies first Debiopharm milestone
  • 3/25/13 - MSM is pleased to announce the appointment of Dr. Edward Kislauskis to its Scientific Advisory Board
  • 11/3/2012 - Andrea Corcoran appointed as CFO and in-house counsel
  • 12/15/2011 - MSM Protein Press Release
  • 5/25/2010 - Appointment of Dr. Christopher Hentschel to the Board of Directors
  • 8/20/2009 - Debiopharm and MSM Protein Technologies
  • 7/30/2009 - Merck Serono and MSM Protein Technologies Establish Drug Discovery Collaboration Targeted to Complex Cell Surface Receptors
  • 11/10/2008 - MSM Protein Technologies secures funding from Cystic Fibrosis Foundation
  • 10/17/2006 - MSM Protein Technologies Inc. forms drug discovery collaboration with U.K.-based Cambridge Antibody Technology

MSM Protein Technologies

© Copyright 2005- MSM Protein Technologies, Inc. • 1393 Main Street • Waltham, MA 02451
Phone: 617-440-5900 • Email:

Site Map • Privacy & Terms